Cortecs replies
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Cortecs, the biotechnology company, yesterday sought to explain its handling of Glen Travers's departure as chief executive earlier this week. Without commenting on Mr Travers directly, Michael Flynn, the new acting chief executive, indicated that it was the "natural course of events" for entrepreneurial companies to outgrow their founders. Lord Patten of Wincanton, the former Conservative cabinet minister, has since been appointed Cortecs' non-executive chairman.
The company also announced yesterday that it has signed new marketing agreements with Becton Dickinson of the US that could earn it a minimum $15m over five years.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments